Biogen (BIIB) Construction in Progress (2016 - 2025)
Biogen has reported Construction in Progress over the past 17 years, most recently at $163.1 million for Q4 2025.
- Quarterly results put Construction in Progress at $163.1 million for Q4 2025, down 47.11% from a year ago — trailing twelve months through Dec 2025 was $163.1 million (down 47.11% YoY), and the annual figure for FY2025 was $163.1 million, down 47.11%.
- Construction in Progress for Q4 2025 was $163.1 million at Biogen, down from $308.4 million in the prior quarter.
- Over the last five years, Construction in Progress for BIIB hit a ceiling of $1.9 billion in Q1 2021 and a floor of $163.1 million in Q4 2025.
- Median Construction in Progress over the past 5 years was $711.1 million (2022), compared with a mean of $754.1 million.
- Biggest five-year swings in Construction in Progress: increased 15.38% in 2022 and later tumbled 68.38% in 2024.
- Biogen's Construction in Progress stood at $770.3 million in 2021, then grew by 15.38% to $888.8 million in 2022, then grew by 9.74% to $975.4 million in 2023, then tumbled by 68.38% to $308.4 million in 2024, then tumbled by 47.11% to $163.1 million in 2025.
- The last three reported values for Construction in Progress were $163.1 million (Q4 2025), $308.4 million (Q4 2024), and $975.4 million (Q4 2023) per Business Quant data.